Thorne HealthTech, Inc. (THRN) es una empresa que cotiza en bolsa en el Consumo Defensivo sector, operando dentro de la Packaged Foods industria. La empresa tiene su sede en New York City, NY, United States. El CEO actual es Paul F. Jacobson.
THRN tiene fecha de IPO 2021-09-23, 544 empleados a tiempo completo, cotiza en el NASDAQ Global Select, una capitalización de mercado de $550.63M.
Thorne HealthTech, Inc., a science-driven wellness company, provides solutions and personalized approaches to health and wellness in the United States and internationally. It offers various health tests, such as sleep, stress, weight management, gut health, heavy metals, biological age, and other health tests that generate molecular portraits for its customers, as well as develops nutritional supplements and offers wellness education solutions. The company uses the Onegevity platform to map, integrate, and understand the biological features that describe the state of an individual's health, as well as provide actionable insights and personalized data, products, and services that help individuals to take a proactive approach to improve and maintain their health. It primarily serves healthcare professionals, professional athletes, and professional sports and Olympic teams. Thorne HealthTech, Inc. was founded in 1984 and is headquartered in New York, New York.
